Hou Xue, Xu Meihua, Li Jie, Li Rui, Zhang Jinzhi, Ju Jing
Department of Clinical Laboratory, Yantaishan Hospital, Yantai 264000, China.
Department of Pharmacy, Traditional Chinese Medical Hospital of Huangdao District, Qingdao 266500, China.
Evid Based Complement Alternat Med. 2021 Nov 19;2021:4434504. doi: 10.1155/2021/4434504. eCollection 2021.
To investigate the clinical effects of Chinese medicine decoction combined with glucocorticoid in treating children with primary nephrotic syndrome.
A total of 70 children with pediatric nephritis nephrotic syndrome treated at Weifang People's Hospital from January 2019 to December 2019 were randomly allocated to the therapy group and the control group, each with 35 cases. The control group was treated with conventional Western medicine, and the therapy group received Western medicine and Chinese medicine. After 12 weeks of treatment, the therapeutic effect of the two groups was compared.
After receiving the treatment, the levels of urine protein (UPro), triglyceride, and cholesterol were significantly decreased in the two groups ( < 0.05), and these levels in the therapy group were much lower than those of the control group ( < 0.05). However, the level of albumin (ALB) was predominantly increased in the two groups after treatment ( < 0.05), and this level in the therapy group was much higher than that of the control group ( < 0.05). Moreover, the immune indicators, coagulation function, and recurrence rate were noticeably improved after treatment ( < 0.05), and the therapy group was better than the control group ( < 0.05). Furthermore, the comparison of renal function indexes, liver function indexes, and blood routine between the two groups showed no statistical significance in the incidence of adverse reactions between the two groups ( > 0.05).
For the treatment of refractory nephrotic syndrome in children, based on conventional shock therapy, the addition of traditional Chinese medicine (Liuwei Dihuang pill decoction) remedy can significantly improve the disease symptoms in children and improve the efficacy, and the incidence of adverse reactions is low.
探讨中药汤剂联合糖皮质激素治疗小儿原发性肾病综合征的临床疗效。
选取2019年1月至2019年12月在潍坊市人民医院治疗的70例小儿肾炎肾病综合征患儿,随机分为治疗组和对照组,每组35例。对照组采用传统西医治疗,治疗组采用西医和中药联合治疗。治疗12周后,比较两组的治疗效果。
治疗后,两组患儿的尿蛋白(UPro)、甘油三酯和胆固醇水平均显著降低(<0.05),且治疗组的这些水平远低于对照组(<0.05)。然而,两组患儿治疗后的白蛋白(ALB)水平均主要升高(<0.05),且治疗组的该水平远高于对照组(<0.05)。此外,治疗后免疫指标、凝血功能和复发率均明显改善(<0.05),且治疗组优于对照组(<0.05)。此外,两组肾功能指标、肝功能指标和血常规比较,两组不良反应发生率差异无统计学意义(>0.05)。
对于小儿难治性肾病综合征的治疗,在传统冲击治疗的基础上,加用中药(六味地黄丸汤剂) remedy可显著改善患儿疾病症状,提高疗效,且不良反应发生率低。